Pliant Therapeutics Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Total Funding:$207.4M
Industry:Pharma
Founded:2016
Lead Investor(s):Cowen Healthcare Investments

Industry Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Pliant Therapeutics's estimated annual revenue is currently $15.3M per year.
  • Pliant Therapeutics received $62.0M in venture funding in July 2018.
  • Pliant Therapeutics's estimated revenue per employee is $201,000
  • Pliant Therapeutics's total funding is $207.4M.

Employee Data

  • Pliant Therapeutics has 76 Employees.
  • Pliant Therapeutics grew their employee count by 25% last year.
  • Pliant Therapeutics currently has 23 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
Trifecta Clinic...
$15.3M763%N/A-N/A
DURECT Corporat...
N/A125N/AN/A-N/A
Rancho BioScien...
$13.1M6523%N/A-N/A
ApotheCom
$53.1M264N/AN/A-N/A
Tlc Pharmacy
$10.1M504%N/A-N/A
Otsuka America
$13.5M6720%N/A-N/A
endpoint Clinic...
$62.1M30910%N/A-N/A
GCAM
$22.5M1125%N/A-N/A
VistaGen Therap...
N/A17N/AN/A-N/A
ZO Skin Health
$69.5M3462%N/A-N/A
Missing a competitor? Contribute!?
Submit

Pliant Therapeutics is focused on discovering, developing and commercializing breakthrough treatments for fibrotic diseases. By harnessing the therapeutic potential of integrin biology and TGF- modulation, Pliant aims to prevent or even reverse fibrosis to address the needs of many patients. The company also aims to build a patient registry for certain areas of fibrotic disease to both increase understanding of natural disease progression, and fuel biomarker discovery. Pliant's co-founders include world-renowned researchers from University of California, San Francisco (UCSF), who bring broad experience in fibrosis biology and small molecule chemistry. Together, the Pliant team is dedicated to translating scientific advances in fibrosis biology into novel therapies for patients in need.

keywords:N/A

76

Number of Employees

$15.3M

Revenue (est)

23

Current Jobs

25%

Employee Growth %

$207.4M

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Pliant Therapeutics News

09/07/2019 - Pliant Therapeutics Reports Positive Results of Phase 1b ...

SOUTH SAN FRANCISCO, June 27, 2019 /PRNewswire/ -- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company focused on ...

09/08/2019 - Orchard Therapeutics Further Strengthens Board of Directors with Appointment of John Curnutte, M.D., Ph.D.

He currently serves on the board of directors of Pliant Therapeutics. Dr. Curnutte holds an A.B. in Biochemistry and Molecular Biology from ...

04/09/2019 - Pliant Therapeutics Reports Positive Results of Phase 1 ...

SOUTH SAN FRANCISCO, Calif., April 9, 2019 /PRNewswire/ -- Pliant Therapeutics, Inc., a biotechnology company focused on discovering, ...

Pliant Therapeutics Funding

DateAmountRoundLead InvestorsReference
2016-02-19$45.0MAThird Rock Ventures, LLCArticle
2018-07-17$62.0MBCowen Healthcare InvestmentsArticle

Pliant Therapeutics Executive Hires

DateNameTitleReference
2016-04-29Hans HullChief Business OfficerArticle
2017-01-06Rik DerynckScientific FounderArticle
2017-09-27Katerina LeftherisVice President of ChemistryArticle
2018-05-09Hoyoung HuhChairmanArticle
2019-01-04Keith CummingsChief Financial OfficerArticle